Identification of Eupatilin from Artemisia argyi as a Selective PPARα Agonist Using Affinity Selection Ultrafiltration LC-MS
暂无分享,去创建一个
[1] Kewu Zeng,et al. Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[2] C. Bala,et al. Surface Plasmon Resonance (SPR) Biosensors in Pharmaceutical Analysis , 2015, Critical reviews in analytical chemistry.
[3] W. Hsu,et al. A novel natural Nrf2 activator with PPARγ-agonist (monascin) attenuates the toxicity of methylglyoxal and hyperglycemia. , 2013, Toxicology and applied pharmacology.
[4] M. Rhee,et al. Anti-inflammatory activities and mechanisms of Artemisia asiatica ethanol extract. , 2014, Journal of ethnopharmacology.
[5] T. Ochiya,et al. DSE-FRET: A new anticancer drug screening assay for DNA binding proteins , 2014, Cancer science.
[6] W. Price,et al. A fragmentation study of isoflavones in negative electrospray ionization by MSn ion trap mass spectrometry and triple quadrupole mass spectrometry. , 2007, Rapid communications in mass spectrometry : RCM.
[7] D. Ribnicky,et al. Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture , 2014, Diabetes, obesity & metabolism.
[8] Juan J. Marugan,et al. A High Throughput Screening Assay System for the Identification of Small Molecule Inhibitors of gsp , 2014, PloS one.
[9] Q. Shi,et al. PPARγ agonist from Chromolaena odorata. , 2012, Journal of natural products.
[10] Karim Benkirane,et al. Vascular and Cardiac Effects in Hypertension , 2022 .
[11] B. Spiegelman,et al. International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors , 2006, Pharmacological Reviews.
[12] William Fenical,et al. Screening natural products for inhibitors of quinone reductase-2 using ultrafiltration LC-MS. , 2011, Analytical chemistry.
[13] K. Hahm,et al. The Anti-inflammatory Effects of Acidic Polysaccharide from Artemisia capillaris on Helicobacter pylori Infection , 2013, Journal of cancer prevention.
[14] D. Ribnicky,et al. An Extract of Artemisia dracunculus L. Inhibits Ubiquitin-Proteasome Activity and Preserves Skeletal Muscle Mass in a Murine Model of Diabetes , 2013, PloS one.
[15] Nathan R. Qi,et al. Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione* , 2012, The Journal of Biological Chemistry.
[16] S. Noha,et al. Honokiol: A non-adipogenic PPARγ agonist from nature☆ , 2013, Biochimica et biophysica acta.
[17] Richard B. van Breemen,et al. Screening for Ligands of Human Retinoid X Receptor-α Using Ultrafiltration Mass Spectrometry , 2007 .
[18] P. Forgó,et al. Antiproliferative Activity of Artemisia asiatica Extract and Its Constituents on Human Tumor Cell Lines , 2014, Planta Medica.
[19] J. Bouajila,et al. Composition and anti-oxidant, anti-cancer and anti-inflammatory activities of Artemisia herba-alba, Ruta chalpensis L. and Peganum harmala L. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[21] J. Bolton,et al. Ultrafiltration tandem mass spectrometry of estrogens for characterization of structure and affinity for human estrogen receptors , 2005, Journal of the American Society for Mass Spectrometry.
[22] D. Ribnicky,et al. Bioactives of Artemisia dracunculus L. Mitigate the Role of Ceramides in Attenuating Insulin Signaling in Rat Skeletal Muscle Cells , 2012, Diabetes.
[23] I. W. Nilsen,et al. Efficient Screening of Marine Extracts for Protease Inhibitors by Combining FRET Based Activity Assays and Surface Plasmon Resonance Spectroscopy Based Binding Assays , 2013, Marine drugs.
[24] G. Massolini,et al. Resveratrol and Its Metabolites Bind to PPARs , 2014, Chembiochem : a European journal of chemical biology.
[25] H. Kwon,et al. Anti-diabetic effect of amorphastilbol through PPARα/γ dual activation in db/db mice. , 2013, Biochemical and biophysical research communications.
[26] Tian Zhu,et al. High-Throughput Screening (HTS) and Hit Validation to Identify Small Molecule Inhibitors with Activity against NS3/4A proteases from Multiple Hepatitis C Virus Genotypes , 2013, PloS one.
[27] R. V. van Breemen,et al. Development of a screening assay for ligands to the estrogen receptor based on magnetic microparticles and LC-MS. , 2008, Combinatorial chemistry & high throughput screening.
[28] Kyeong Lee1,et al. A Peroxisome Proliferator-Activated Receptor-gamma Agonist and Other Constituents from Chromolaena odorata , 2009, Planta medica.
[29] Noeris K. Salam,et al. Novel PPAR‐gamma Agonists Identified from a Natural Product Library: A Virtual Screening, Induced‐Fit Docking and Biological Assay Study , 2007, Chemical biology & drug design.
[30] L. J. Hardies,et al. Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus , 2007, Diabetologia.
[31] B. Staels,et al. Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARα and PPARγ agonists , 2004 .
[32] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[33] G. Firestone,et al. Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression* , 2009, Journal of Biological Chemistry.